Pharma & Biotech Patent Litigation Summit North America

This industry-led event has been carefully curated alongside inhouse counsels from innovator, generic, biologic and biosimilar organisations to determine latest international patent litigation frontiers that is shaping global pharma and biotech patent strategy. 

Topics will cover how Chief IP Counsels and General Counsels are structuring and mitigating risks in cross-border litigation cases, how to enhance your patent protection post Re: Cellect and how to be prepared for Europe’s biggest patent market shift, the UPC. 

Don’t miss RWS’s Jim Burns speaking on a panel titled: Global Patent Litigation Strategy: How to Structure and Time Global Settlement? Cost Constraints, Risk Management and Life Cycle Management.